Laboratory Evaluation of Functional Diarrhea and Diarrhea-Predominant Irritable Bowel Syndrome in Adults
Publication Date: September 2, 2019
Key Points
Key Points
These guidelines apply to the evaluation of the immunocompetent patient with “watery” diarrhea of at least four weeks duration.
- This excludes those patients with bloody diarrhea; diarrhea with signs of fat malabsorption; presentations with alarm features such as weight loss, anemia, and hypoalbuminemia; those patients with a family history of inflammatory bowel disease (IBD), colon cancer, or celiac disease; and those with a travel history to regions with recognized specific diarrhea-related pathogens.
Treatment
...Table 1. Summa...
...s presenting with chronic diarrhea, A...
...atients presenting with chronic dia...
...ts presenting with chronic diarrhea, AG...
...s presenting with chronic diarrhea with no tra...
.... In patients presenting with chronic diarrh...
...In patients presenting with chronic diar...
...n patients presenting with chronic diarrhe...
...Syndrome in Adults (IBS-D) Clinical Decision...
...isit gastro.org/guidelinesapp to learn about...